Lv45
710 积分 2022-09-27 加入
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial
4天前
已完结
Synergy between chemotherapy and immunotherapy in the treatment of established murine solid tumors
7天前
已关闭
Sijunzi decoction, a classical Chinese herbal formula, improves fatigue symptoms with changes in gut microbiota in chronic fatigue syndrome: A randomized, double-blind, placebo-controlled, multi-center clinical trial
13天前
已完结
Karnasphota: A Neuroprotective Herb from the Treasure of Ayurveda
14天前
已完结
Review: N1-methyl-pseudouridine (m1Ψ): Friend or foe of cancer?
17天前
已完结
mRNA-based cancer therapeutics
21天前
已完结
Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial
1个月前
已完结
Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB–IIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial
1个月前
已完结
The peptide woods are lovely, dark and deep: Hunting for novel cancer antigens
2个月前
已完结
Antigen cross-presentation by dendritic cells: A critical axis in cancer immunotherapy
2个月前
已完结
皖公网安备34019202002308
